35
Views
7
CrossRef citations to date
0
Altmetric
Theme: General - Review

Renin–angiotensin system blockade and reduction of cardiovascular risk: future perspectives

Pages 1585-1591 | Published online: 10 Jan 2014
 

Abstract

Treatment with renin–angiotensin system blockers (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers) has shown clear benefits in distinct stages of cardiovascular disease. These treatments lower blood pressure and prevent the appearance of markers of subclinical disease (such as microalbuminuria), reduce cardiovascular and renal events in patients with subclinical lesions, and prolong survival in patients with clinical disease or organ dysfunction. Despite this unquestionable benefit, the residual risk in patients receiving these treatments often continues to be high and, consequently, strategies to reduce such risk are required. The present article reviews options that may help to reduce cardiovascular disease in such patients. They include efforts of primary prevention in healthy individuals, stricter therapeutic goals, comprehensive risk control, a more complete blocking of the renin–angiotensin system and the use of combinations of drugs with synergistic protective mechanisms.

Financial & competing interests disclosure

A de la Sierra has received honoraria for consultancy or participation in scientific meetings funded by Bayer-Schering Pharma, Daiichi-Sankyo, Menarini, Merck-Serono, Novartis and sanofi-aventis. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.